What: Chief Healthcare Executive examines the growing business case for increased funding in women’s health, forecasting new opportunities and challenges.
Key line: [Details not provided].
Source: Chief Healthcare Executive.
Employers are responding to rising fertility costs by increasing access to preconception care, according to new research.
A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.
A federal judge temporarily halted Trump’s planned deep NIH funding cuts after attorneys general from 22 states sued to block the move.
An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
The abrupt cancellation of NIH meetings may hinder critical medical research.
A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.
The New York Times reports that a freeze on US foreign aid has decimated women’s health care globally, affecting millions seeking maternity care and other services.
The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
ProPublica’s review of Texas hospital data reveals a more than 50% increase in sepsis rates among pregnant women after abortion was banned.
Beyond recreation, cannabis is being evaluated for therapeutic benefits in women’s care.
A federal judge stopped Trump’s move to freeze federal funding that supports essential health programs.
Research shows the causes of maternal mortality differ widely from state to state.
Cannabis producers are exploring new treatment areas in women’s health.
An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.
An analysis of emerging investment trends shaping the future of women’s health research.
The New York Times investigates whether testosterone therapy could benefit menopausal women.